These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 6757026)
1. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026 [No Abstract] [Full Text] [Related]
2. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Meinert CL; Knatterud GL; Prout TE; Klimt CR Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376 [No Abstract] [Full Text] [Related]
3. The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy. Diabetes; 1975; 24 Suppl 1():65-184. PubMed ID: 1090475 [No Abstract] [Full Text] [Related]
4. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results. Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344 [No Abstract] [Full Text] [Related]
5. [Do oral antidiabetics play a part in the cardiovascular mortality of diabetics? Apropos of the University Group Diabetes Program report and the controversies it has raised]. Canivet J; Deuil R; Eschwege E; Hazard J; Lubetzki J; Tchobroutsky G; Valleron A Presse Med (1893); 1971 Dec; 79(53):2437-44. PubMed ID: 5156529 [No Abstract] [Full Text] [Related]
6. The UGDP--tolbutamide and mortality. Knowles HC Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432 [No Abstract] [Full Text] [Related]
7. Phenformin and vascular complications of diabetes. Med Lett Drugs Ther; 1972 Jan; 14(1):1-2. PubMed ID: 4567560 [No Abstract] [Full Text] [Related]
8. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures]. Tattersall RB Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219 [No Abstract] [Full Text] [Related]
9. A progress report on the University Group Diabetes Program. Prout TE Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369 [TBL] [Abstract][Full Text] [Related]
10. The controversial American University Group Diabetes Study--a look at sulfonylurea and biguanide therapy. Kilo C; Williamson JR Horm Metab Res Suppl; 1985; 15():102-4. PubMed ID: 3908276 [No Abstract] [Full Text] [Related]
11. Progress report on the prophylactic use of oral hypoglycemic drugs in asymptomatic diabetes: neurovascular studies. Feldman R; Crawford D; Elashoff R; Glass A Adv Metab Disord; 1973; 2():Suppl 2:557-67. PubMed ID: 4720386 [No Abstract] [Full Text] [Related]
13. [Evaluation of therapy of diabetes mellitus, with special reference to the control of diabetes mellitus with oral antidiabetics]. Kadota I Nihon Rinsho; 1969 Aug; 27(8):2136-50. PubMed ID: 4901777 [No Abstract] [Full Text] [Related]
14. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results. Goldner MG; Knatterud GL; Prout TE JAMA; 1971 Nov; 218(9):1400-10. PubMed ID: 4941698 [No Abstract] [Full Text] [Related]
15. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus]. Polosa P; Mughini L Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556 [No Abstract] [Full Text] [Related]
16. Fatal vascular complications in diabetic patients treated by diet, sulfonylureas and insulin. A retrospective study. Fidel J; Nelken L Isr J Med Sci; 1974 Jul; 10(7):702-6. PubMed ID: 4852026 [No Abstract] [Full Text] [Related]
17. Therapy of early diabetes. The University Group Diabetes Program. Prout TE Adv Metab Disord; 1973; 2():Suppl 2:501-20. PubMed ID: 4720381 [No Abstract] [Full Text] [Related]